SMAD1 and neuroblastoma: We treated ATRA-sensitive neuroblastoma cell lines (CHP-134, NB-13, TGW, SK-N-SH) with FK506 or rapamycin for four hours, which in all cases resulted in increased phosphorylation of SMAD1/5/9, indicating an increase in BMP signaling activity (Fig. 2D).